Results 81 to 90 of about 4,828 (174)

Preclinical characterisation of the protective capacity of an anti-nucleoprotein hRSV monoclonal antibody. [PDF]

EBioMedicine
Farías MA, Andrade CA, Loaiza RA, Rodríguez-Guilarte L, Muñoz JT, Pereira-Sánchez P, Muñoz-Durango N, Pizarro-Ortega MS, Diethelm-Varela B, Pereira-Serrano A, Ramírez RA, Chávez JL, Bohmwald K, Soto JA, González PA, Bueno SM, Kalergis AM.   +16 more
europepmc   +1 more source

Palivizumab for Severe Respiratory Syncytial Virus Infection in Immunocompetent Adults: A Case Series. [PDF]

Infect Drug Resist
Zhong JY, Yeh TK, Huang HP, Ho CM, Liu PY, Fu YC.   +5 more
europepmc   +1 more source

Strengthening RSV prevention in early life through new generation strategies. [PDF]

J Pediatr (Rio J)
Mejias A, Ramilo O.
europepmc   +1 more source

Respiratory syncytial virus (RSV) antibody and small-molecule drugs: current status of clinical translation and challenges. [PDF]

Front Microbiol
Liu H, Zhong H, Liu H.
europepmc   +1 more source

Analysis of the economically justifiable price of nirsevimab to prevent respiratory syncytial virus infection in Korea. [PDF]

Hum Vaccin Immunother
Han HJ, Jang S, Dahye R, Lee H, Lee J, Bae EJ, Soudani S, Suh HS.   +7 more
europepmc   +1 more source

Discovery and molecular mechanism of potent neutralizing antibody from humanized mice with respiratory syncytial virus. [PDF]

PLoS Pathog
Zhang Z, Feng R, Zhang L, Yang Q, Chen X, Wang X, Nie C, Peng W, Wang X, Zhu L, Guo Y, Sun Z.   +11 more
europepmc   +1 more source

Is Palivizumabe a Protective Factor for the Development of Asthma in Children? A Systematic Review With Metanalysis. [PDF]

Pediatr Pulmonol
Manini MB, da Silva NC, de Castro RA, Grotta MB, Toro AADC.   +4 more
europepmc   +1 more source

RSV vaccine development: advances and fusion protein-focused strategies. [PDF]

Front Immunol
Xu W, Katte RH, Lu M.
europepmc   +1 more source

Prevalence of Resistance-Associated Mutations in RSV F Protein Against Monoclonal Antibodies Prior to Widespread Implementation: Findings From a Prospective German Pediatric Cohort. [PDF]

Influenza Other Respir Viruses
Wetzke M, Le DB, Tometten I, Ritter S, Lübke N, Timm J, Dilthey A, Panning M, Walker A, Happle C.   +9 more
europepmc   +1 more source

Improvement in Palivizumab Administration in Severely Immunocompromised Children: A Single-institution Quality Improvement Initiative. [PDF]

Pediatr Qual Saf
Hijano DR, Allen DC, Burlison J, Ross HS, Ferrolino JA, Dallas RH, Hayden RT, Morton TH, Greene WL, Wolf J, Ramilo O, Flynn PM, Cross SJ.   +12 more
europepmc   +1 more source